United Kingdom: Privilege

Claimants who hired a private intelligence firm covertly to extract privileged information from the other side's solicitor have lost their worldwide freezing orders—even though their underlying fraud claim remains strong.

The Court of Appeal has delivered a landmark ruling on abuse of process, upholding findings that claimants engaged in unlawful conduct by covertly obtaining privileged litigation material from the defendants' solicitor through deception. The judgment addresses whether such conduct warrants striking out applications and discharging freezing orders worth hundreds of millions of dollars in a complex fraud case involving stock lending transactions.

Lewis Silkin's In-House Employment Lawyers Coffee Break Episode 26 explores the critical issue of legal privilege in corporate communications, examining the landmark Aabar v Glencore case and its implications for in-house counsel. This episode delves into when and how privilege protections apply to internal legal advice, offering practical guidance for employment lawyers navigating the complex boundaries between legal and business communications. Understanding privilege is essential for protecting sensitive

Our Corporate Energy Transition team has advised the founders of Island Green Power, a UK-based renewable energy developer focused on utility-scale solar and battery energy storage system (BESS) projects...

Navigating tax disputes with HMRC can be a complex and daunting process. This "need to know" series sheds light on the essential elements. In this note, we cover HMRC's formal information gathering powers.

This article explores the consequences of a recent judgment disapplying/disproving the existence of the shareholder rule...

Mourant host this Mondaq webinar discussing: 'Recent Global Private Capital Developments from a Channel Islands Perspective'.

This appeal arose from an application by the Defendant Respondents ("the Defendants") for wasted costs orders against the Defendant Appellant ("Walker Prestons"), ...

Scipharm, a pharmaceutical company, and Moorfields, an NHS hospital trust, were parties to a pharmaceutical development agreement.